RLAY Relay Therapeutics Inc
P/E
--
Forward P/E
--
Price/Sales
286.82
Beta
1.752
Div Yield
--
Market Cap
--
Company Analysis
Latest News
🔴 Relay Therapeutics Inc is trading 4.9% down today on rate concerns and broader biotech selling
Relay Therapeutics Inc is trading 4.9% down at $13.84 amid broader risk-off pressure in growth and biotech names following a stronger-than-expected jobs...
🔴 Relay Therapeutics Inc is trading 4.05% down today, giving back gains from a recent rally
Relay Therapeutics Inc is trading 4.05% down today at $14.68, giving back a portion of its sharp gains from June 2, 2026. • No fresh company-specific news,...
🟢 Relay Therapeutics Inc is trading 18.44% up
RLAY is trading at $16.89, up 18.44%.
Relay Therapeutics Zovegalisib Shows 60% Response Rate in Rare Vascular Disease
Relay Therapeutics announced initial Phase 2 ReInspire trial data for zovegalisib. The study targets PIK3CA-driven vascular anomalies, which are rare disorders...
🔴 Relay Therapeutics Inc is trading 3.7% down today on normal volatility
Relay Therapeutics Inc is trading 3.7% down at $13.53 today on normal volatility within recent trading ranges and quiet news flow. • No fresh company...